1 – 13 of 13
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI : The ProScreen Randomized Trial
(
- Contribution to journal › Article
- 2023
-
Mark
Screening for prostate cancer : evidence, ongoing trials, policies and knowledge gaps
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen : a pilot study
(
- Contribution to journal › Article
- 2019
-
Mark
A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy : An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer
(
- Contribution to journal › Article
-
Mark
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice : A microsimulation screening analysis
(
- Contribution to journal › Article
- 2014
-
Mark
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
(
- Contribution to journal › Article
- 2012
-
Mark
Prostate-Cancer Mortality at 11 Years of Follow-up
(
- Contribution to journal › Article
- 2010
-
Mark
Lead-time in the european randomised study of screening for prostate cancer
(
- Contribution to journal › Article
- 2009
-
Mark
Test Sensitivity in the European Prostate Cancer Screening Trial: Results from Finland, Sweden, and the Netherlands
(
- Contribution to journal › Article
-
Mark
Screening and Prostate-Cancer Mortality in a Randomized European Study
(
- Contribution to journal › Article
-
Mark
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
(
- Contribution to journal › Article
- 2002
-
Mark
Large-scale randomized prostate cancer screening trials : Program performances in the european randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial
(
- Contribution to journal › Article